Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$63.83 - $80.0 $273,128 - $342,320
-4,279 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$76.85 - $89.45 $15,293 - $17,800
-199 Reduced 4.44%
4,279 $332,000
Q4 2021

Feb 11, 2022

SELL
$74.57 - $87.19 $46,606 - $54,493
-625 Reduced 12.25%
4,478 $384,000
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $33,786 - $38,293
-458 Reduced 8.24%
5,103 $410,000
Q2 2021

Aug 03, 2021

SELL
$80.5 - $88.01 $7,567 - $8,272
-94 Reduced 1.66%
5,561 $448,000
Q1 2021

May 07, 2021

SELL
$76.38 - $86.03 $7.23 Million - $8.14 Million
-94,639 Reduced 94.36%
5,655 $477,000
Q4 2020

Feb 04, 2021

SELL
$75.39 - $82.36 $1.16 Million - $1.27 Million
-15,375 Reduced 13.29%
100,294 $8.05 Million
Q3 2020

Nov 13, 2020

SELL
$78.33 - $90.73 $1.98 Million - $2.3 Million
-25,325 Reduced 17.96%
115,669 $9.3 Million
Q2 2020

Aug 06, 2020

SELL
$78.66 - $94.14 $289,311 - $346,246
-3,678 Reduced 2.54%
140,994 $12.1 Million
Q1 2020

Apr 29, 2020

BUY
$71.57 - $93.3 $82,448 - $107,481
1,152 Added 0.8%
144,672 $11.7 Million
Q4 2019

Feb 11, 2020

BUY
$76.7 - $88.45 $368,620 - $425,090
4,806 Added 3.46%
143,520 $12 Million
Q3 2019

Nov 05, 2019

SELL
$81.4 - $89.78 $230,524 - $254,256
-2,832 Reduced 2.0%
138,714 $12.1 Million
Q2 2019

Aug 15, 2019

SELL
$73.44 - $82.41 $125,068 - $140,344
-1,703 Reduced 1.19%
141,546 $11.6 Million
Q1 2019

May 13, 2019

BUY
$64.48 - $81.31 $257,920 - $325,240
4,000 Added 2.87%
143,249 $10.9 Million
Q4 2018

Feb 08, 2019

BUY
$61.45 - $77.8 $8.34 Million - $10.6 Million
135,747 Added 3876.27%
139,249 $9.17 Million
Q3 2018

Nov 08, 2018

BUY
$70.71 - $77.75 $141 - $155
2 Added 0.06%
3,502 $270,000
Q2 2018

Aug 08, 2018

BUY
$63.43 - $75.41 $222,005 - $263,935
3,500 New
3,500 $258,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Doyle Wealth Management Portfolio

Follow Doyle Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.